Compugroup Medical (ETR:COP) has been given a €60.00 ($71.43) target price by research analysts at HSBC in a report released on Friday. The brokerage currently has a “buy” rating on the stock. HSBC’s target price suggests a potential upside of 14.83% from the stock’s previous close.
A number of other brokerages have also weighed in on COP. Baader Bank set a €52.00 ($61.90) price objective on Compugroup Medical and gave the company a “neutral” rating in a report on Tuesday, December 19th. Berenberg Bank set a €53.00 ($63.10) price objective on Compugroup Medical and gave the company a “neutral” rating in a report on Friday, December 15th. Warburg Research set a €56.00 ($66.67) price objective on Compugroup Medical and gave the company a “buy” rating in a report on Thursday, December 14th. Commerzbank set a €62.00 ($73.81) price objective on Compugroup Medical and gave the company a “buy” rating in a report on Thursday, December 14th. Finally, Deutsche Bank set a €65.00 ($77.38) price objective on Compugroup Medical and gave the company a “buy” rating in a report on Tuesday, November 14th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of €58.43 ($69.56).
Shares of Compugroup Medical (ETR:COP) traded up €0.95 ($1.13) during trading hours on Friday, reaching €52.25 ($62.20). The company had a trading volume of 163,220 shares, compared to its average volume of 56,213. Compugroup Medical has a 12 month low of €36.12 ($43.00) and a 12 month high of €59.25 ($70.54). The firm has a market cap of $2,780.00 and a price-to-earnings ratio of 63.72.
TRADEMARK VIOLATION WARNING: “Compugroup Medical (COP) Given a €60.00 Price Target by HSBC Analysts” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2018/01/27/compugroup-medical-cop-given-a-60-00-price-target-by-hsbc-analysts.html.
CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.
Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.